General Information of Drug Off-Target (DOT) (ID: OTPL1HRB)

DOT Name Plakophilin-3 (PKP3)
Gene Name PKP3
Related Disease
Bladder cancer ( )
Carcinoma ( )
Epithelial ovarian cancer ( )
Melanoma ( )
Neoplasm ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Prostate cancer ( )
Prostate neoplasm ( )
Tuberculosis ( )
Urinary bladder cancer ( )
Urinary bladder neoplasm ( )
Autoimmune disease ( )
Pemphigus vulgaris ( )
Non-small-cell lung cancer ( )
Digestive system neoplasm ( )
Lung adenocarcinoma ( )
Lung cancer ( )
Lung carcinoma ( )
Malignant mesothelioma ( )
Malignant pleural mesothelioma ( )
Nasopharyngeal carcinoma ( )
UniProt ID
PKP3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00514
Sequence
MQDGNFLLSALQPEAGVCSLALPSDLQLDRRGAEGPEAERLRAARVQEQVRARLLQLGQQ
PRHNGAAEPEPEAETARGTSRGQYHTLQAGFSSRSQGLSGDKTSGFRPIAKPAYSPASWS
SRSAVDLSCSRRLSSAHNGGSAFGAAGYGGAQPTPPMPTRPVSFHERGGVGSRADYDTLS
LRSLRLGPGGLDDRYSLVSEQLEPAATSTYRAFAYERQASSSSSRAGGLDWPEATEVSPS
RTIRAPAVRTLQRFQSSHRSRGVGGAVPGAVLEPVARAPSVRSLSLSLADSGHLPDVHGF
NSYGSHRTLQRLSSGFDDIDLPSAVKYLMASDPNLQVLGAAYIQHKCYSDAAAKKQARSL
QAVPRLVKLFNHANQEVQRHATGAMRNLIYDNADNKLALVEENGIFELLRTLREQDDELR
KNVTGILWNLSSSDHLKDRLARDTLEQLTDLVLSPLSGAGGPPLIQQNASEAEIFYNATG
FLRNLSSASQATRQKMRECHGLVDALVTSINHALDAGKCEDKSVENAVCVLRNLSYRLYD
EMPPSALQRLEGRGRRDLAGAPPGEVVGCFTPQSRRLRELPLAADALTFAEVSKDPKGLE
WLWSPQIVGLYNRLLQRCELNRHTTEAAAGALQNITAGDRRWAGVLSRLALEQERILNPL
LDRVRTADHHQLRSLTGLIRNLSRNARNKDEMSTKVVSHLIEKLPGSVGEKSPPAEVLVN
IIAVLNNLVVASPIAARDLLYFDGLRKLIFIKKKRDSPDSEKSSRAASSLLANLWQYNKL
HRDFRAKGYRKEDFLGP
Function May play a role in junctional plaques.
Tissue Specificity
Isoform PKP3a is found in desmosomes of most simple and stratified epithelia. Not found in foreskin fibroblasts and various sarcoma-derived cell lines. Beside dendritic reticular cells of lymphatic follicles not found in non-epithelial desmosome-bearing tissues. Isoform PKP3b is abundant in the desmosomes of stratified epithelial cell but absent in simple epithelial cells, it is also expressed in the colon and its tumors.
Reactome Pathway
Formation of the cornified envelope (R-HSA-6809371 )
Keratinization (R-HSA-6805567 )

Molecular Interaction Atlas (MIA) of This DOT

22 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Bladder cancer DISUHNM0 Strong Altered Expression [1]
Carcinoma DISH9F1N Strong Genetic Variation [2]
Epithelial ovarian cancer DIS56MH2 Strong Biomarker [3]
Melanoma DIS1RRCY Strong Biomarker [3]
Neoplasm DISZKGEW Strong Biomarker [4]
Ovarian cancer DISZJHAP Strong Biomarker [3]
Ovarian neoplasm DISEAFTY Strong Biomarker [3]
Prostate cancer DISF190Y Strong Biomarker [5]
Prostate neoplasm DISHDKGQ Strong Biomarker [5]
Tuberculosis DIS2YIMD Strong Genetic Variation [6]
Urinary bladder cancer DISDV4T7 Strong Altered Expression [1]
Urinary bladder neoplasm DIS7HACE Strong Altered Expression [1]
Autoimmune disease DISORMTM moderate Biomarker [7]
Pemphigus vulgaris DISENR62 moderate Posttranslational Modification [7]
Non-small-cell lung cancer DIS5Y6R9 Disputed Altered Expression [8]
Digestive system neoplasm DISPOJCT Limited Altered Expression [9]
Lung adenocarcinoma DISD51WR Limited Altered Expression [8]
Lung cancer DISCM4YA Limited Biomarker [8]
Lung carcinoma DISTR26C Limited Biomarker [8]
Malignant mesothelioma DISTHJGH Limited Biomarker [10]
Malignant pleural mesothelioma DIST2R60 Limited Altered Expression [10]
Nasopharyngeal carcinoma DISAOTQ0 Limited Biomarker [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 22 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 3 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Temozolomide DMKECZD Approved Plakophilin-3 (PKP3) affects the response to substance of Temozolomide. [20]
Arsenic trioxide DM61TA4 Approved Plakophilin-3 (PKP3) decreases the response to substance of Arsenic trioxide. [21]
DTI-015 DMXZRW0 Approved Plakophilin-3 (PKP3) affects the response to substance of DTI-015. [20]
------------------------------------------------------------------------------------
4 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Plakophilin-3 (PKP3). [12]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Plakophilin-3 (PKP3). [18]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 affects the phosphorylation of Plakophilin-3 (PKP3). [19]
Coumarin DM0N8ZM Investigative Coumarin decreases the phosphorylation of Plakophilin-3 (PKP3). [19]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Plakophilin-3 (PKP3). [13]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of Plakophilin-3 (PKP3). [14]
Triclosan DMZUR4N Approved Triclosan increases the expression of Plakophilin-3 (PKP3). [15]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Plakophilin-3 (PKP3). [16]
Resveratrol DM3RWXL Phase 3 Resveratrol decreases the expression of Plakophilin-3 (PKP3). [17]
------------------------------------------------------------------------------------

References

1 Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.Urology. 2012 Jan;79(1):240.e1-8. doi: 10.1016/j.urology.2011.08.049. Epub 2011 Nov 25.
2 An alternative promoter of the human plakophilin-3 gene controls the expression of the new isoform PKP3b.Cell Tissue Res. 2014 Jan;355(1):143-62. doi: 10.1007/s00441-013-1736-1. Epub 2013 Nov 1.
3 PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer.Biochem Biophys Res Commun. 2019 Jan 8;508(2):646-653. doi: 10.1016/j.bbrc.2018.11.163. Epub 2018 Dec 4.
4 Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation.Exp Cell Res. 2018 Aug 15;369(2):251-265. doi: 10.1016/j.yexcr.2018.05.026. Epub 2018 May 24.
5 Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.Prostate. 2007 Jan 1;67(1):83-106. doi: 10.1002/pros.20505.
6 Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants.PLoS One. 2016 Feb 12;11(2):e0148649. doi: 10.1371/journal.pone.0148649. eCollection 2016.
7 Pemphigus vulgaris autoimmune globulin induces Src-dependent tyrosine-phosphorylation of plakophilin 3 and its detachment from desmoglein 3.Autoimmunity. 2014 Mar;47(2):134-40. doi: 10.3109/08916934.2013.866100. Epub 2013 Dec 16.
8 Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.Cancer Res. 2005 Aug 15;65(16):7102-10. doi: 10.1158/0008-5472.CAN-04-1877.
9 Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer.Cancer Detect Prev. 2008;32(3):236-50. doi: 10.1016/j.cdp.2008.08.002. Epub 2008 Sep 17.
10 Expression of plakophilin 3 in diffuse malignant pleural mesothelioma.Histol Histopathol. 2018 Sep;33(9):995-1004. doi: 10.14670/HH-11-996. Epub 2018 May 3.
11 Dinitrosopiperazine-decreased PKP3 through upregulating miR-149 participates in nasopharyngeal carcinoma metastasis.Mol Carcinog. 2018 Dec;57(12):1763-1779. doi: 10.1002/mc.22895. Epub 2018 Sep 19.
12 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
13 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
14 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
15 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
16 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
17 Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007 Dec 15;67(24):12007-17. doi: 10.1158/0008-5472.CAN-07-2464.
18 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
19 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
20 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
21 The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics. 2010 Aug 13;3:37. doi: 10.1186/1755-8794-3-37.